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Abstract Establishing the temporal and concentration
profiles of neurotransmitters during synaptic release is an
essential step towards understanding the basic properties of
inter-neuronal communication in the central nervous sys-
tem. A variety of ingenious attempts has been made to gain
insights into this process, but the general inaccessibility of
central synapses, intrinsic limitations of the techniques
used, and natural variety of different synaptic environments
have hindered a comprehensive description of this funda-
mental phenomenon. Here, we describe a number of
experimental and theoretical findings that has been instru-
mental for advancing our knowledge of various features of
neurotransmitter release, as well as newly developed tools
that could overcome some limits of traditional pharmaco-
logical approaches and bring new impetus to the description
of the complex mechanisms of synaptic transmission.
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Introduction
The time course of synaptic currents is one of the main
factors determining how a single neuron integrates infor-
mation coming from different inputs. The duration of
postsynaptic currents can vary over two orders of magni-
tude depending on the kinetics of the postsynaptic receptors
being activated. For example, excitatory glutamatergic
currents decay with time constants (τdecay) as short as
2 ms when mediated by AMPA receptors alone (AMPARs),
while the recruitment of NMDA receptors (NMDARs)
prolongs the decay up to hundreds of milliseconds.
Similarly, glycine-receptor-mediated inhibitory currents
are fast (τdecay∼3 ms) while GABAA receptor (GABAAR)
mediated events are approximately three to four times
slower. Since these receptors operate in conditions of non-
equilibrium, small variations in the neurotransmitter profile
can alter considerably the time course of synaptic currents.
It is normally thought that, following release, neurotrans-
mitters in the cleft reach a peak concentration that is in the
millimolar range, and decays rapidly (τdecay=0.1–1 ms),
due to diffusion, re-uptake, binding to receptors/trans-
porters, or enzymatic breakdown. However, at some
synapses in the central nervous system, receptors are
exposed to small and prolonged neurotransmitter transients
[1–4]. This longer concentration profile gives rise to
synaptic currents that decay slowly (depending on the
kinetic properties of the receptors) and leads to an extended
period of synaptic excitation or inhibition. Therefore,
determining the concentration profile of neurotransmitters
released during synaptic events is essential for understand-
ing the effects of individual synaptic inputs onto their
corresponding postsynaptic targets. The major difficulties
to address this issue experimentally are posed by the
inaccessibility of narrow synaptic clefts, uncertainties in
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mitter diffusion within and outside the cleft, and by the fact
that synapses vary widely in shape, size, density of
neurotransmitter receptors, and quantal properties of neu-
rotransmitter release [5–10]. As a consequence, estimates of
the neurotransmitter time course can only be rough
approximations, often representing average estimates
obtained through indirect approaches, primarily pharmaco-
logical, which can only partially characterize a few aspects
of this phenomenon.
Here, we discuss the various features of synaptic release
that can lead to different neurotransmitter concentration
profiles in the cleft. We describe the pitfalls and advantages
of the experimental approaches used so far, and briefly
overview some of the emerging imaging approaches that
could refine current estimates of the neurotransmitter
lifetime once liberated in the synaptic cleft.
Quantal Size and Multivesicular Release
At first sight, an estimate of the neurotransmitter concen-
tration profile in the synaptic cleft could be easily obtained
if one knew how many neurotransmitter molecules are
stored in each synaptic vesicle, how many vesicles fuse
with the presynaptic terminal in response to an action
potential, and how much of the vesicle content is released
in the synaptic cleft with every partial or full fusion event.
In practice, getting detailed information about each one of
these steps has proven to be a challenging task.
The first attempt to measure how much neurotransmitter
is released at the neuromuscular junction was probably
done by Acheson [11], who suggested that 10
−15mmoles
acetylcholine (ACh) is released per presynaptic nerve
stimulation. This value was inferred from titration experi-
ments through exogenous ACh applications which, howev-
er, reproduced only roughly the time course of miniature
end-plate potentials (mEPPs). Iontophoresis approaches
proposedatenfoldincreaseintheabovevalue(10
−14 mmoles
[12]), but still suffered from profound underestimates of
ACh dilution from the iontophoresis pipette to the end-plate
and presumably from overestimates of the end-plate area
where the ACh receptors (AChRs) are distributed (the
fraction of the total iontophoretic current passed by ACh
was also an approximation [13]). The major breakthroughs
came from two studies that provided information on: (1) the
postsynaptic area activated by a quantum of neurotransmit-
ter (<2 μm
2 [14]); (2) the number of ACh molecules
released by each quantum [13]. It is worth noting that for
the experiments described by [13], the snake end-plate
preparation was placed in an oil–water interface, which
therefore minimized the dilution artifacts mentioned previ-
ously. The authors performed two consecutive titrations to
calculate the charge that had to be applied to the
iontophoresis pipette to reproduce a mEPP reasonably
accurately, and the number of ACh molecules released
from the iontophoresis pipette per unit of charge. The final
approximation of <10
4 ACh molecules/vesicle suggested
that in a postsynaptic area of 1 μm
2, with a 50-nm-wide
synaptic cleft, the peak ACh concentration is ~0.3 mM, and
in a 50-nm-wide synaptic vesicle the ACh concentration is
~260 mM [13]. There is rough agreement between these
estimates and the more detailed ones obtained later on at
the frog and mouse neuromuscular junctions (peak neuro-
transmitter concentration in the cleft ~1 mM, but see Fig. 2
in [15] for an evaluation of how the ACh concentration
changes as it spreads over the postjunctional area).
Therefore, to this day, the hypothesis that synaptically
released ACh reaches millimolar concentrations at the
neuromuscular junction remains the most widely accepted.
The use of carbon-fiber microelectrodes and amperom-
etry has been instrumental to obtaining analogous estimates
from cells that release electro-oxidizable molecules such as
catecholamines and indoleamines. Although the technique
was initially developed to detect neurotransmitter release
from chromaffin cells [16], it has also been used on central
neurons [17]. Briefly, electro-active neurotransmitters are
oxidized by the carbon-fiber, and the reaction causes a
positive deflection in the current measurement obtained
through the microelectrode. A read-out of the vesicular
neurotransmitter concentration is readily obtained by con-
verting the charge transfer during the positive deflection
into number of moles by using Faraday’sc o n s t a n t .
Accordingly,
N ¼
Q
n   F
where N=number of moles of neurotransmitter, Q=charge
transfer per positive deflection (C), n=number of electrons
involved in the reaction, F=Faraday constant. It was
estimated that the vesicular concentration of catecholamine
in chromaffin cells is 190–300 mM [16] and that of
dopamine in midbrain neurons is ~300 mM [17].
Amperometric measures offer excellent time resolution,
but because neurotransmitters are degraded as they react
with the carbon-fiber, estimates of the time course of release
can potentially be slightly inaccurate (i.e., the neurotrans-
mitter concentration decreases as it reacts with the carbon-
fiber). The major limitations of this technique, however, are
posed by the facts that carbon-fibers (which have a diameter
of a few micrometers) cannot access the synaptic cleft
(which has a width of tens of nanometers), and are not suited
for neurotransmitter concentration measurements at synap-
ses that do not release non electro-oxidizable molecules.
At central synapses, direct measures of the vesicular
concentration of glutamate (as well as GABA, glycine, and
290 Mol Neurobiol (2009) 40:289–306other neurotransmitters) have not been obtained. However,
numerous biochemical studies have been crucial to provide
some sort of ballpark figure. For example, immunoisolation
of synaptic vesicles with antibodies against synaptophysin
has shown that, under experimental conditions that enable
the maintenance of an energy gradient across the vesicular
membrane, glutamate is ten times more concentrated in
synaptic vesicles that in the cytoplasm [18]. Given that (1)
there is ~0.8 μmol glutamate/mg synaptophysin, (2)
synaptophysin represents ~7% of total vesicle proteins, (3)
the volume of synaptic vesicles is assumed to be ~1 μl/mg
total protein, it was suggested that the glutamate concen-
tration in synaptic vesicles is ~60 mM, and certainly
<150 mM, a value imposed by the Donnan law [18]. These
estimates are in rough agreement with those obtained from
synaptic vesicles isolated with other purification protocols,
yielding values of 70–210 mM [19].
It is worth noting, however, that all these quantifications
have been obtained through a series of conversions that at
some point require knowledge of the inner volume of
synaptic vesicles. This information has been traditionally
obtained through electron microscopy studies, but the size
of synaptic vesicles can be altered by the chemical fixation
steps required for tissue preparation (see [20] for one of the
most detailed analyses of synaptic vesicle structure). Since
the synaptic vesicle volume scales with the third power of
its radius, small errors in length can lead to much bigger
errors in volumes. Therefore, it is still unclear whether the
synaptic vesicle volume varies significantly across the
entire population of synaptic vesicles in presynaptic
terminals [20, 21] or not [22]. There is also some debate
on whether the neurotransmitter concentration varies across
synaptic vesicles of different size [23, 24], or with different
copies of vesicular neurotransmitter transporters [25]. Since
the final neurotransmitter concentration in the cleft depends
on the total number of neurotransmitter molecules released,
vesicles with similar neurotransmitter concentration but
different volume can still lead to different neurotransmitter
concentration profiles in the cleft.
Do synapses always release one vesicle or are they also
capable of releasing more than one? Despite the fact that
multiple vesicles are docked at most presynaptic terminals,
the number of active synaptic connections among neurons
generally exceeds the total number of quanta released during
synaptic stimulations [26, 27]. This combined anatomical
and electrophysiological evidence has led to the hypothesis
that, at various peripheral and central synapses, not more
than one vesicle of neurotransmitter is released from a
given active zone (univesicular release hypothesis) [28, 29].
If the hypothesis holds for those single-site connections
where quantal events can be clearly resolved (i.e., when
miniature events are much bigger than the baseline noise of
the recordings, and are not distorted by the cable properties
of neuronal dendrites [30]), it does not necessarily imply a
unique mode of release in time and across the different
synaptic contacts that a neuron forms [31].
In the last decade, numerous studies have proposed that
multiple release events can also occur (multivesicular release
hypothesis) [30, 32–41]. One line of evidence in support of
multivesicular release is the occurrence of miniature
currents that arise in brief succession, do not summate
linearly, and are not independent on one other [30]. A more
indirect approach relies on the measure of the amplitude of
evoked EPSCs when varying release probability (PR) in the
presence of low-affinity competitive antagonists [32, 34,
40] (described in a following section of this review). Such
antagonists are less efficient in blocking the response when
the receptors are exposed to higher concentrations of
neurotransmitter. Consequently, if increasing PR increases
the amount of neurotransmitter released from individual
synapses (as suggested by the multivesicular release
hypothesis), it also leads to reduced sensitivity of postsyn-
aptic currents to low-affinity antagonists. Conversely, if
increasing PR only increases the number of active synapses,
but each synapse still releases one quantum, no change in
the effect of low-affinity antagonists on postsynaptic
currents is expected [32, 34, 40]. Multivesicular release
can result in a prolonged exposure time of postsynaptic
receptors to the agonist if the neurotransmitter vesicles are
not released simultaneously, thereby leading to postsynaptic
currents that decay more slowly. This, however, is a rather
unspecific effect, that can arise for other reasons than
multivesicular release. For example, it can occur when
varying the mode of vesicle fusion [42] or the extent of
neurotransmitter spillover among neighboring synapses
[43]. A clear distinction between these scenarios is difficult
to establish and it is probably for this reason that it remains
arduous to unequivocally prove the occurrence of multi-
vesicular release at certain synapses.
The extent to which the neurotransmitter concentration
profile in the cleft is altered by multivesicular release also
depends on the temporal characteristics of each synaptic
vesicle fusion, and on the number of neurotransmitter
molecules released during successive fusion events. For
example, if only a few neurotransmitter molecules were
releasedinthecleftduringthe secondfusion,theprofileofthe
neurotransmitter transient would be only marginally different
from that observed when univesicular release takes place.
From a functional standpoint, having the ability to release
more than one synaptic vesicle endows synapses with the
abilitytoexpandtheirdynamicrangeofoutputsinresponseto
synaptic stimulations and presumably to enhance the reliabil-
ity with which information is conveyed from one neuron to
the other. This simple scenario, however, may be complicated
bythefactthatthemagnitudeofthepostsynapticresponseand
the pattern of activity of the postsynaptic neuron can be
Mol Neurobiol (2009) 40:289–306 291shaped by non-linear interactions between neurotransmitter
receptors and voltage-gated conductances [41].
Partial Versus Full Fusion Events
Ca
2+ entry in the presynaptic terminal triggers a complex
cascade of events that ultimately results in fusion of
neurotransmitter vesicles with the presynaptic membrane.
Whether this process involves complete or transient fusion
between vesicles and synaptic terminals remains a hotly
debated issue that began with the ultrastructural detection of
omega-shaped profiles at the active zone of the neuromus-
cular junction after prolonged electrical stimulation [44,
45]. Because electron microscopy only provides a snapshot
of an ongoing process, however, it remained unclear
whether these structures represented a vesicle in the process
of releasing its content [45] or one that was being
immediately retrieved [44]. Since these initial observations
a number of functional approaches ranging from amperom-
etry [46] to capacitance measurements [47] and imaging of
fluorescent styryl dyes and pH sensors [48, 49] have
confirmed the occurrence of transient fusion although, to
date, it remains unclear whether this represents a typical or
rare mode of neurotransmitter release.
At some synapses, the net prevalence of partial/full fusion
events can be tested by performing capacitance measure-
ments from the presynaptic terminal [47]. Since membrane
capacitance is linearly proportional to cell surface, it
increases any time a vesicle fuses with the presynaptic
membrane. Accordingly, step-like increases and decreases
in cell capacitance have been observed in chromaffin cells
and neurons [47, 50, 51]. These are attributed to vesicle
fusion and retrieval events, respectively, because (1) the
amplitude distribution of capacitance steps matches that of
synaptic vesicle surface area obtained through morpholog-
ical studies [51, 52]; (2) the time course of fluorescence
loss from dye-loaded synaptic vesicles matches that of cell
capacitance increase [52]; (3) the frequency of the up-steps,
like that of release events, depends on the external [Ca
2+]
and drops in the presence of the protease trypsin [47]; (4)
up-steps can only be recorded from the side of presynaptic
terminals that faces the postsynaptic cell [47].
The capacitance measurements are generally performed
by coupling a phase lock-in amplifier with a voltage-clamp
amplifier. The cell (or the patch, if the recordings are in
cell-attached configuration) is voltage-clamped and forced
to undergo sinusoidal voltage membrane oscillations. The
lock-in amplifier decomposes the real (Re) and imaginary
components (Im) of the admittance, which are in-phase and
90°-out-of-phase with the membrane voltage, respectively.
Changes in Re reflect conductance changes, whereas
changes in Im reflect changes in capacitance. Therefore,
one can also obtain information on the fusion pore
conductance (GP) by applying the equation:
GP ¼
Re2 þ Im2
Re
whereas the diameter of the fusion pore (DP) is expressed as:
DP ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4GPrl
p
r
(ρ=saline resistivity (100Ω cm), λ=pore length (generally
set at 15 nm, the length of a gap junction hemichannel)) [53].
The time constant of neurotransmitter discharge can be
described as:
t ¼
pd3
V
6rD*GP
(dV=vesicle diameter, D*=apparent neurotransmitter diffu-
sion constant).
At the calyx of Held, 97% of the events detected with
capacitance measurements have GP>288 pS and DP>2.3 nm,
and are interpreted as full fusion events because they can lead
to complete neurotransmitter release from synaptic vesicles in
τ<0.54 ms. If this were true, miniature excitatory postsynaptic
currents (mEPSCs) would be predicted to rise with 10–90%
rise time=0.15–0.36 ms, a range that closely matches the one
observed experimentally for most mEPSCs (0.21–0.27 ms)
[47]. For the remaining 3% of the events GP=66 pS, leading
to DP=1.1nmandτ=2.3ms[47]. In this case, the probability
of releasing completely the synaptic vesicle content in the
extracellular space (ECS) depends on how long the fusion
pore remains open. This parameter varies across a relatively
broad range (10 ms–1s ) ,s ot h a tt h er a r eo c c u r r e n c eo fn o n -
quantal events cannot be completely ruled out.
At hippocampal synapses, partial fusion (although not
necessarily partial neurotransmitter discharge) initially
emerged as the predominant mode of neurotransmitter
release [54, 55]. This feature has been proposed to speed
the recycling time of synaptic vesicles substantially, to 1–
2s[ 54] (cf. 15–20 s for clathrin-mediated endocytotic
pathways [56, 57]), and therefore enable reliable synaptic
transmission during high-frequency stimulation. Such a fast
recycling time would be primarily limited by the time of
vesicular reacidification via the H
+-pump and of neuro-
transmitter refilling through vesicular transporters. It should
be noted, however, that this net prevalence of partial fusion
events is not unanimously observed [57, 58] and may be
biased by some methodological and analytical caveats [57].
For example: (1) lack of complete FM1-43 loss from
synaptic vesicles may reflect dye partitioning in membranes
neighboring the site of neurotransmitter release, rather than
the occurrence of partial fusion events; (2) the fast decline
in the fluorescence of the pH-sensitive GFP synapto-
292 Mol Neurobiol (2009) 40:289–306pHluorin after exocytosis may be due to diffusion of the
indicator away from the release site rather than to rapid
endocytosis, and can be accounted for by enlarging the
region of interest used for quantifying fluorescent signals
[57]. The incidence of partial fusion events may vary across
synapses with different release probabilities or experiencing
different levels of synaptic stimulation [49], and possibly
changes during development [59], but additional work will
help to test these hypotheses in further detail [57].
One intriguing approach that has been recently used to
measure the likelihood of partial/full fusion events involves
the use of quantum dots as reporters of different vesicular pH
and fusion modes [49, 60]. Quantum dots with a hydrody-
namic diameter of ~15 nm (matching the intravesicular
diameter) have a peak emission at 605 nm, with an intensity
that apparently increases with pH [49]. The acidic pH of
synaptic vesicles (5.5) rises to extracellular values (7.4)
upon opening of the fusion pore. The consequent increase in
the fluorescence signal from the quantum dots is recovered
if the fusion pore closes back (partial fusion), but is
followed by an irreversible loss of fluorescence if the
quantum dot is released into the extracellular environment
(full fusion) [49]. This approach suggests that partial fusion
is limited to ~20% of all fusion events, and involves
primarily synaptic vesicles with relatively high intrinsic
release probability (readily releasable pool [49]). A preva-
lence of full fusion events would shift the source of
variability in the peak concentration of released neurotrans-
mitter to differences in vesicle size and vesicle filling that
we mentioned in the previous chapter [25].
In addition to the mode of release, the lifetime of the
neurotransmitter in the ECS is also affected by a number of
other factors. Once released into the synaptic cleft, the
neurotransmitter is subject to three main phenomena: (1)
binding to postsynaptic receptors or to degrading enzymes in
the ECS; (2) diffusion and escape from the synapse; (3)
binding to nearby transporter molecules. All these processes
act in a concerted, but not necessarily simultaneous, way to
rapidly terminate the neurotransmitter actions and enable
reliable high-frequency signaling among neurons. In the next
sections, we analyze how each one of them contributes to
shape the lifetime of neurotransmitters in the synaptic cleft.
Neurotransmitter Enzymatic Breakdown and Receptor
Binding
At the neuromuscular junction, mEPPs rise in <1 ms and
decay with a half-time of about 1–1.5 ms at room
temperature. The duration and variability of mEPPs is
enhanced in the presence of molecules like prostigmine or
eserine, which inhibit the activity of ACh esterase, the
degrading enzyme for ACh present in the ECS [61–63].
Hydrolysis of ACh is generally thought to be rapid and,
based on the previous observations, to represent the major
mechanism responsible for the fast time course of mEPPs at
the neuromuscular junction [62]. When the enzymatic
breakdown of ACh is reduced, however, the decay of
mEPPs (3.5–4 ms) is not entirely accounted for by free
diffusion of the neurotransmitter away from the cleft (2 ms
[64]), estimated through a simple analytic approach initially
described by [65]a n d[ 66]. What other mechanism could
underlie this discrepancy? Although one would have been
naturally inclined to dismiss the accuracy of the adopted
mathematical model, Katz and Miledi [62] perceptively
noticed that the effects of ACh esterase inhibitors on the
decay of mEPPs could be partially counteracted by curare or
α-bungarotoxin, antagonists of the nicotinic AChRs mediat-
ing the mEPPs. These drugs, per se, reduced the amplitude
of the mEPPs, as well as their variability and decay time.
The proposed hypothesis was that ACh unbinding and
rebinding to its receptors delays the neurotransmitter
clearance from the synaptic cleft. If one assumes that there
are more AChRs than ACh molecules released during
synaptic events, and that curare unbinding from AChRs is
negligible during the time course of the mEPPs, then the
duration of the ACh transient becomes inversely proportion-
al to the number and lifetime of ACh–AChRs complexes.
That is to say: if p is the fraction of ACh molecules initially
bound to AChRs, the decay of the ACh transient is 1/(1−p)
slower than what it would be in the case of free diffusion
(p=0). This delay, as well as the variability of mEPPs
amplitude, is largely reduced by curare because by lowering
p the drug brings the time course of cholinergic events close
to the lifetime of single ACh–AChRs complexes.
The proposed mechanism strongly depends on the kinetic
profile of the AChR-antagonist interaction and consequently
may not be equally relevant for other pharmacological
compounds. More importantly, it is unlikely to have a major
impact when the density of postsynaptic receptors is low (like
at central synapses and, possibly, at the neuromuscular
junctionitself).AlthoughAChisbrokendownextracellularly,
apart from ATP and peptides, other transmitters are not
degraded. Rather, they are subject to diffusion and reuptake,
which therefore represent the main phenomena that shape the
time course of synaptic events.
Diffusion and Reuptake
The time course of the concentration change of a solute in a
solution is quantitatively described by Fick’s second law of
diffusion:
@Cx
@t
¼ D
@2Cx
@X 2
Mol Neurobiol (2009) 40:289–306 293where Cx=concentration of the solute at distance x from a
reference point, D=diffusion coefficient of the solute in
free, aqueous solution, and t=time. This formalism, which
describes the temporal development of a concentration
profile in a homogeneous and free medium, cannot be used
as it is to define the movement of neurotransmitter
molecules in the brain. The brain may not necessarily
behave as a homogeneous (or isotropic) medium (although
this may be a more or less of a concern for different brain
regions); the apparent diffusion coefficient of the neuro-
transmitter in the ECS (D*) is generally smaller than the
one measured in free solution (D), due to the geometrical
and molecular complexity of the ECS in respect to free
medium [67]; part of the neurotransmitter molecules can be
removed from the ECS as they are enzymatically degraded
or taken up by transporters. An evaluation of the applica-
bility of Fick’s second law to the brain environment has
been proposed by Nicholson and Phillips [67], by approx-
imating this structure to a porous medium with extracellular
volume fraction α and tortuosity l. The equation, which
now reads:
@C
@t
¼
D 
l2 r2C þ
Q
a
  v  r C  
f ðCÞ
a
takes into account the contribution of hindered diffusion
(first term), the effective volume within which molecules
move (second term), bulk flow (if any, third term) and
neurotransmitter loss due to enzymatic breakdown, uptake,
etc. (fourth term) (C=neurotransmitter concentration, t=
time, D*=apparent neurotransmitter diffusion coefficient,
l=tortuosity, Q=source strength, α=extracellular volume
fraction, v=velocity vector) [67, 68]. The variable α can be
thought of as the fraction of brain tissue that is not occupied
by neuronal or glial processes or by vasculature and that in
electron micrographs may appear as a series of “empty”
spaces (note that in reality the ECS is far from being
“empty”, hosting a variety of macromolecules and viscous
components that contribute to the smaller value of D*i n
respect to D). Various methods indicate that in the brain of
newborn mammals, on average, α=0.36–0.46 and reaches a
value of 0.2 during adulthood [69]. The tortuosity l,
instead, measures the extent to which diffusion in the brain
is slowed down in comparison to free solution
(l ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
D=D  p
). It does not change significantly with
development (λ∼1.6), but may vary across different brain
regions and in different animal species (1.39<l<1.77 [69]
—note that this is a relatively wide range because it implies
a 40% difference in D*, which can influence significantly
the extent of postsynaptic receptor activation [70]). Multi-
ple factors contribute to λ: the geometry of the ECS (e.g.
number and shape of neighboring structures), dead-end
microdomains [71], the ECS viscosity due to the presence
of proteins and various macromolecules within the extra-
cellular matrix, as well as any interactions between neuro-
transmitters and receptors or charged molecules in the ECS
[68]. The geometric and viscous components of l are often
referred to as lg and lv. In a simplified 3D environment
where the ECS resembles a series of packed convex cells,
one could consider l=lg·lv (but see [72, 73] for a more
detailed mathematical evaluation of how dead-end pores
contribute to brain tortuosity). The numerical range across
which lg can vary is described by the equation [68, 74]:
lg ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
3   a
2
r
Therefore, for 0<α<1, one has 1<lg<1.225. The discrep-
ancy between this upper limit for lg and the experimental
value of l=1.6 is likely due to lv, the specific/non-specific
binding effects mentioned previously (whose effective
contribution to l, however, remains undetermined) and the
greater morphological complexity of the brain.
A quantitative estimate of α and l is not necessarily
trivial. Whereas various methods have been explored to
estimate D*o rl [75–78], a simultaneous measure of α and
λ, including both the viscous and the geometrical compo-
nent, has only been obtained initially with radiotracers [79]
and later on with real-time iontophoresis [67]. The use of
radiotracers has been hampered by the fact that they require
long perfusion times and post-mortem processing of the
tissue [69]. The iontophoresis technique involves monitor-
ing the diffusion of small (MW<100 Da), cell-impermeable
ions (e.g., tetramethylammonium, tetraethylammonium, α-
naphthalene sulfonate) from an iontophoresis electrode to
an ion-selective one, mounted at a fixed distance from each
other (few hundreds of micrometers) [67]. The signal
detected by the ion-selective electrode is displayed as a
diffusion curve which is used to extract the values of α and
l (in addition to k′, a measure of neurotransmitter loss [67]).
The main caveat of this approach, as pointed out by [75], is
that it only provides information about diffusion of small
molecules towards one point in the tissue without resolving
possible spatial patterns of diffusion. This limitation can be
partly overcome with integrative optical imaging
approaches [75, 77]. By monitoring the diffusion profile
of fluorescently labeled molecules with high molecular
weight (e.g. Texas Red dextrans up to tens of kilodaltons
[75] or quantum dots [77]), one can derive D* for smaller
neurotransmitter molecules. The technique relies on a
mathematical description of the image of the three-
dimensional diffusion of dyes on a two-dimensional plane.
To avoid this step, which nevertheless approximates the
experimental results reasonably well [77], and to gain an
even better time resolution of diffusion, the time–space
profile of small fluorescent molecules (e.g., Alexa Fluo
350) can be examined in a thin focal plane, like that of a
294 Mol Neurobiol (2009) 40:289–306two-photon laser scanning microscope [76, 78]. In all cases,
it is assumed that dyes diffuse in the ECS with radial
symmetry from a point source. The goodness of this
approximation can be verified post-hoc by analyzing the
goodness of a Gaussian fit of the diffusion profile of the
dye, which generally holds.
An exhaustive comparison of how the estimate of the
diffusion parameters vary with different experimental
approaches is still missing. Although in principle the two-
photon approach offers the best spatial and time resolution,
it remains unclear whether this effectively improves the
accuracy of the numerical estimates. The major caveat
common to all approaches, in our opinion, is that they all
provide bulk measures of diffusion over distances (tens or
hundreds of micrometers) and times (milliseconds) that
largely exceed the spatiotemporal scales of synapses
(nanometers, microseconds). An estimate of D*glutamate
from physiological experiments has been performed by
Nielsen et al. [80] through an evaluation of the effect of
dextran on the kinetics and amplitude of spillover-mediated
currents at cerebellar mossy fiber-granule cell synapses
D*
glutamate ¼
 
0:33   0:13 mm2=ms; mean   S:E:M:
 
, but it
is currently unknown whether this estimate can be
considered reasonably accurate for other types of synapses.
One major point of uncertainty is whether any change in
neurotransmitter diffusion occurs between the synaptic cleft
and neighboring extrasynaptic regions. Given that the
majority of the tortuosity factor is contributed by geomet-
rical factors, and there is no geometric obstacle to diffusion
in the synaptic cleft, it could be feasible that D*cleft<<
D*extrasynaptic areas [81].
Why is it relevant to have such a meticulous estimate of
D* and λ in the brain? Slowly diffusing neurotransmitters
persist in the ECS for a relatively long time, and have
higher chances of binding to receptors. Therefore, by
altering the neurotransmitter concentration profile, varying
D* can also alter the open probability of receptors, as long
as these are far from saturation. Indeed, this prediction has
been tested in a number of simulation environments for a
range of D*=0.1–0.75 μm
2/ms [80, 82, 83] (here the upper
value equals the diffusion coefficient of glutamine in free
medium at 25°C [84]) and also experimentally [85]. For
example, at hippocampal mossy fiber synapses on CA3
pyramidal cells, lowering D*glutamate by 50% enhances
significantly activation of AMPAR, NMDAR, and kainate
receptors [85]. Whether even smaller changes in D* can
still lead to physiologically relevant effects on receptor
activation and inter-neuronal signaling remains to be
evaluated: varying D* alters the neurotransmitter concen-
tration profile, but whether this leads to small or big
changes in postsynaptic responses depends on the proper-
ties of the activated receptors. By using the kinetic models
of four receptor types described in Fig. 1, we have analyzed
how significant changes in receptor activation could occur
with neurotransmitter transients of different amplitude and
duration (Fig. 2). A wide range of uncertainties in the
estimate of the neurotransmitter concentration profile can
alter significantly the peak open probability of postsynaptic
receptors. For example, the extent of AMPAR activation is
particularly susceptible to changes in the profile of the
neurotransmitter transient. One could then speculate that
this may alter profoundly the temporal integration of
synaptic inputs, given the high temporal precision with
which certain synapses can operate [86].
The effects of changes in D* could be particularly
pronounced for extrasynaptic receptors scattered around the
postsynaptic density and in dendritic shafts [70]. For
example, at glutamatergic synapses the occupancy of
high-affinity slow-desensitizing NMDARs may be en-
hanced by increasing the overall tortuosity of the synaptic
and non-synaptic milieu [83]. The physiological relevance
of a differential activation of extrasynaptic receptors
remains a matter of current investigation.
Needless to say, activation of these distant receptors is
extremely susceptible to the presence, distribution, and
relative abundance of transporters which can quickly buffer
neurotransmitter molecules in hundreds of microseconds
[39, 87, 88] and slowly remove them from the ECS, at rates
that depend on the membrane potential, temperature, and
concentration of co-transported ions (~4–27 s
−1 for VR=
−140–0m V ,a tR T[ 89]). A quantitative analysis of
glutamate transporter density has been performed by Lehre
and Danbolt [90], and appears to vary among different
brain regions, depending on the developmental stage of the
preparation. For example, in adult rats, the glutamate
transporter GLT-1 is more abundantly expressed in hippo-
campal CA1 stratum radiatum (8,500 μm
−2)t h a ni n
cerebellar stratum moleculare (740 μm
−2), but it is barely
detectable in newborn rats [91]. In agreement with this
developmental trend, the time course of glutamate clearance
derived from astrocytic recordings in rat hippocampal
stratum radiatum also becomes faster between P12-14 and
>P60 [92]. The contribution of transporters to glutamate
clearance is enhanced at physiological temperature (perhaps
not surprisingly: the temperature dependence of neurotrans-
mitter uptake (Q10=3) is steeper than that of diffusion
(Q10=1.3)) [43] and may be exacerbated during repetitive
presynaptic stimulations [93].
The activity of glial glutamate transporters has also been
analyzed in the context of activation of particular receptor
subtypes that have inhomogeneous subcellular distribu-
tions, like metabotropic glutamate receptors [94] or NR2B-
containing NMDARs [95]. However, an exhaustive char-
acterization of the role of neuronal glutamate transporters is
lacking. Perisynaptic EAAT4 has been shown to control
activation of metabotropic receptors in Purkinje cells [96],
Mol Neurobiol (2009) 40:289–306 295although not in regions lacking the protein zebrin II [97]. A
definitive understanding of the role of EAAT3 is currently
missing [98], partly because there is no sensitive antibody
or specific pharmacological compound that can specifically
target this molecule. Recent experimental and theoretical
estimates suggest that EAAT3 could have a potentially
pivotal role in regulating the profile of the glutamate
transient [78, 98].
Mathematical Simulations of Synaptic Currents
The first attempts to calculate the time course of neuro-
transmitter release in the peripheral system were performed
at a time when anatomical details about the shape and size
of the synaptic cleft were still unavailable [99, 100]. These
estimates, obtained by simply applying the formula for
unhindered diffusion of a substance from a point source
into free medium, were not necessarily aimed at providing a
faithful representation of the neurotransmitter transient, yet
they informed us on the ballpark time window over which
diffusion of neurotransmitters could occur and triggered a
long-lasting debate on the role of this phenomenon in
shaping the profile of synaptic currents. A step forward was
made in the late 1950s by Eccles and Jaeger [61], who
performed a more explicit mathematical analysis of ACh
diffusion in disk- or strip-like synaptic clefts where
diffusion in the z-dimension was prevented by the presence
Fig. 1 The kinetic models used to estimate the time course of
transmitter detected by NMDARs [105], AMPARs [88], glycine [107]
receptors or for a generic agonist-receptor model [118]. All rates are
taken from the original publications and are expressed in ms
−1 or
mM
−1 ms
−1, as appropriate. The rates for the model of del Castillo and
Katz [118] are adapted to produce a current with a τdecay=6 ms.
Agonist molecules are indicated by A, resting states of the receptor by
R, and open states by an asterisk. F indicates the flipped state of a
receptor, whereas the subscript d identifies desensitized states. B
represents blocker molecules (e.g., low-affinity antagonists). Reac-
tions in black have been used to simulate the synaptic responses in
Fig. 2; reactions in gray represent binding of low-affinity antagonist
blockers to their corresponding receptor molecules (D-AA, kynurenic
acid and SR-95531 for NMDARs, AMPARs and glycine receptors,
respectively). All reactions, in black and in gray, have been used for
the analysis presented in Fig. 4
296 Mol Neurobiol (2009) 40:289–306of presynaptic terminals and subsynaptic membranes. The
estimated time course of neurotransmitter concentration had
an approximately exponential behavior with a half decay
time of ~2 ms that roughly matched the time course of
intracellularly recorded EPPs [101].
This general approach, however, could be implemented
by including a description of receptor kinetics and a more
realistic geometry of the synaptic environment and the
surrounding neuropil. Numerically, this can be achieved by
using a series of differential equations that describe the
transitions between different receptor complexes and the
distribution of neurotransmitter molecules by a continuous
density function of space and time. This method is
generally preferred when dealing with simple reaction
schemes and geometries and when numerical accuracy is
required because the error can be progressively reduced by
increasing the number of points at which the estimated
density function is derived [102].
More complex frameworks that include detailed 3D
reconstructions of synaptic structures can also take advan-
tage of Monte Carlo simulations, which deliberately aim to
illustrate the stochastic nature of diffusion of finite numbers
of molecules. Here, diffusion is treated probabilistically and
the position of neurotransmitter molecules is followed in
3D coordinates and time [102–104]. The generated wave-
forms, in this case, appear noisy due to the nature of the
simulated stochastic processes. The error is proportional to
(nN)
−0.5,w h e r en=number of simulated runs and N=
number of neurotransmitter molecules.
Although these approaches can be used to explore the
role of morphological and kinetic variables on synaptic
currents, their predictive values is inevitably hampered by
uncertainties associated with most of the parameters that are
being used. Within a certain cell population, for example,
there can be such a wide range of synapses differing in their
structure, size, number and distribution of receptors, release
properties, and glial coverage [5–10], that the derived
“average” neurotransmitter profile may occur only at a
small fraction of all synaptic contacts.
It is also worth noting that, to some extent, the
neurotransmitter profile concentration varies with the
distance from an active release site, as illustrated in
Fig. 3. In most instances, it does not perfectly follow the
profile of a simple monoexponential function (particularly
long after release has occurred). Therefore, the notional
measurements of the neurotransmitter concentration profile
in the cleft often represent an averaged spatiotemporal
concentration profile across the whole postsynaptic region,
where the receptors contributing to synaptic responses
reside. It should not be interpreted as a faithful represen-
tation of the neurotransmitter concentration profile experi-
enced by all the receptors distributed anywhere across the
entire postsynaptic area.
The Competitive Low-affinity Antagonist Method
The use of competitive antagonists with a fast unbinding
rate for estimating the time course of neurotransmitter in the
cleft was introduced by Clements et al. [105], who
estimated the glutamate transient at excitatory synapses in
cultured hippocampal neurons using a low-affinity compet-
Fig. 2 Effect of altering the profile of the neurotransmitter transient
on the occupancy of different receptors. We used a simplified version
of the kinetic models described in Fig. 1, where the reactions between
receptors and antagonists have been removed (i.e., only the reaction
steps in black). top row Dependency of peak open probability (Po)o n
the duration of monoexponential agonist pulses of different concen-
tration (0.1, 1, and 5 mM). bottom row Dependency of receptor
occupancy (Po) on the amplitude of a 1 ms long agonist transient. The
insets display examples of simulated receptor responses to different
agonist pulses. All simulations were run in ChanneLab (Synaptosolf,
Inc.), using a Runge–Kutta 4 integration
Mol Neurobiol (2009) 40:289–306 297itive NMDAR antagonist. When postsynaptic receptors are
in equilibrium with the antagonist at a Kd concentration, on
average half of them are occupied by the drug (assuming
there is only one antagonist binding site on each receptor).
If the average lifetime of the antagonist–receptor bound
complex is much longer than the length of the agonist
pulse, the response in the presence of the antagonist is half
of that observed in control. If, however, the unbinding rate
of the antagonist is comparable with the length of the
agonist pulse, at least some antagonist molecules unbind
and leave the receptor available for binding the agonist and
eventually open. In this case, two predictions can be made:
first, the current response is less inhibited than calculated at
equilibrium. Second, the rise time of the current response is
slowed down in the presence of antagonist, because at least
some agonist molecules bind (and activate) the receptor
only after the antagonist molecules are unbound. Both
predictions are confirmed by direct experimental observa-
tions in excised patches using antagonists for NMDARs
[105], AMPARs [88], GABAARs [106], and glycine
receptors [107]. More importantly, the amount of inhibition
depends on the actual profile of transmitter in the cleft: the
longer the receptors are exposed to the agonist, the more
antagonist molecules unbind and are replaced by agonist. In
the case of glutamate and glycine receptors, a full dose-
inhibition curve of synaptic currents is available [98, 105,
107]. The data are fitted using only the peak agonist
concentration and its clearance time as free parameters and
the best fits are obtained with agonist pulses of at least
1 mM and shorter than 1 ms.
Fig. 3 Monte Carlo simulation of neurotransmitter diffusion in a disk.
The neurotransmitter (red dots) diffuses in a disk (height h=20 nm,
radius r=250 nm, white wireframes) representing the apposition zone
between pre and postsynaptic terminals (i.e., the cleft). At t=0, 2000
neurotransmitter molecules are released from a point source at the
center of the disk, and diffuse with an apparent diffusion coefficient of
3.3 cm
2/s [80]. a Snapshots of neurotransmitter diffusion 1–2–4–8 μs
after release. b Side view of neurotransmitter diffusion in the cleft, at
the times indicated in a. c Top view of the apposition zone. This is
divided in three concentric disks and annuli, with outer radii r=110–
180–250 nm, respectively. The red arrows indicate the mean distance
between each disk or annulus and the release site. d Examples of the
glutamate waveforms monitored in each one of the three volumes
described in c. Each trace represents the average of 100 Monte Carlo
runs, iterated for 10
4 times with Δt=1 μs. The geometry was created
in silico with an open source program (Blender), imported in a Monte
Carlo simulation environment (M C e l l )a n dr e n d e r e dw i t ht h e
visualization software DReAMM [143, 144]
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with technically straightforward experiments. However,
there are a number of uncertainties for its application: first,
this approach relies on the exact knowledge of the kinetic
properties of postsynaptic receptors and the values for the
binding and unbinding rates of the antagonist. The first can
be obtained either from the kinetic analysis of single
channel recordings [108, 109] or from the analysis of
macroscopic currents exposed to a fast agonist transient
[105, 110, 111]. While the single-channel approach allows
estimate of several rate constants even in models with many
different kinetic states [109, 112], it does not provide
information on the kinetics of desensitization, for example.
In addition, single-channel experiments can only be
performed on channels whose conductance is big enough
to allow good time resolution, like glycine receptors [109,
113] or NMDARs [114], having limited utility for channels
with lower conductance (GABAAR and AMPARs), for
which ultra-fast concentration jumps are preferred. Howev-
er, due to the high time correlation between adjacent points
[115] only few parameters can be estimated with this
method, although a number of different experimental
protocols can provide enough information to determine
the rates in a simplified model that can give a good
description of the experimental results. It is worth noting,
however, that the estimates of these kinetic rates are
generally obtained from extrasynaptic receptors, since
access to synaptic ones is hard to achieve (but see [116]).
This raises the possibility of differences between the two
populations of receptors (the ones activated during synaptic
events and those studied for kinetics analysis) that could be
due to different subunit composition, the modulatory effects
of anchoring proteins, intracellular kinases and phospha-
tases that are lost following patch excision or the effect of
channel density [117], all factors that are difficult to assess
experimentally.
Furthermore, in order to limit the number of fitted
parameters, the transmitter pulse is generally modeled as an
exponential function, while the actual neurotransmitter time
profile obtained from solving diffusion equations may
deviate from this simplified profile (see also Fig. 3). The
exponential approximation used by most authors, however,
allows for a straightforward comparison of the various
available estimates. The most notable limitation of the
competitive low-affinity antagonist approach is that for a
given concentration of antagonist, the same amount of
inhibition of the control response can be observed with
either a short pulse of high agonist concentration or a long
pulse of low agonist concentration [98]. In the first case,
few antagonist molecules unbind during the (short) pulse,
but they are quickly replaced by the agonist present at high
concentration. In the opposite case, there are a lot more
antagonist molecules that unbind during the (long) pulse,
but they are effectively replaced by agonist molecules over
the course of the prolonged low-concentration transient.
This limitation (first indicated by Diamond [98]) can be
observed in the top row of Fig. 4, where the values of peak
agonist concentration and decay time that give a 50%
inhibition at Kd concentration of a fast competitive
antagonist are calculated for published kinetic models of
NMDARs [105], AMPARs [88], glycine receptors [107],
and for a standard del Castillo–Katz model [118] (see Fig. 1
for details on the kinetic rates of each model). It is clear that
very different concentration time courses give rise to the
same level of observed inhibition for all four different
receptors. This feature is entirely independent of the exact
details of the model (number of binding sites, open states,
intermediate shut states, and desensitization rates all differ
in the models included in the figure), and accordingly is
observed with the simplest model where agonist and
antagonist compete for a single binding site (last column
of Fig. 4).
When the results of experiments performed with many
antagonist concentrations are put together the fit of the
resulting dose–inhibition curve with the peak agonist
concentration and decay time as free parameters does not
resolve this ambiguity. To prove this, the responses to an
agonist pulse of 1 mM with τdecay=1 ms are calculated from
the Q matrices (where Q is defined as the matrix containing
the transition rates to and from all states present in the
model [119]) corresponding to the four models of Fig. 1 by
solving with an adaptive Runge–Kutta integration (RK5)
the differential equations that describe the current time
course [120]:
dP
!
ðtÞ
dt
¼ P
!
ðtÞ QðtÞ
where P
!
ðtÞ is the row vector of occupancies of each of the
states of the model and Q(t) is the matrix with the transition
rates. The current amplitude is calculated as the sum of the
occupancies of the open states. A dose–inhibition curve is
determined for seven antagonist concentrations (attaching a
7% error to each calculated point, in line with previously
published data [98, 105, 107]). The time course of agonist
in the cleft (A(t)) is described by the function:
AðtÞ¼
0                  if    t < 0
Apeak   e t
t    if    t   0
 
and the values of Apeak and τdecay that give the best fit of the
dose–inhibition curve are determined with a fitting routine
written in Interactive Data Language (IDL, from ITT Visual
Information solutions, Boulder, Colorado) that uses a
Levenberg–Marquardt algorithm to minimize the sum of
squared deviation (SSD) from the data points.
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values (±1% typically). However, the error on the calculat-
ed estimates is always bigger than one order of magnitude
(in a logarithmic scale) for both parameters. This is because
the two variables are heavily correlated (r varying between
0.996 and 0.999 among the four models tested). We have
therefore determined the region of the two-dimensional
parameter space in which the values of the SSD deviates
from the minimum by less than t
2, where t=2.57 is the
value of the Student’s t statistic with 5 degrees of freedom
(the seven simulated data points minus the two estimated
parameters) that corresponds to the arbitrarily chosen 95%
confidence limit. In other words, all the parameters
included in this region provide an equally good fit of the
dose–inhibition curve. As seen in the plots in the bottom
row of Fig. 4, for all four models, the possible parameters
describing the concentration profile extend over most of the
parameter space in which the search is performed and are
therefore completely undetermined.
The method of the competitive low-affinity antagonist
alone cannot produce unambiguous results, even when the
number of fitted parameters is limited to two. In order to
overcome this problem, Overstreet et al. [106] estimated
that GABA reaches a cleft concentration of 3–5 mM, that
decays with τdecay=0.3–0.6 ms, using a single antagonist
concentration and performing a fit of the whole time course
of GABAergic IPSCs. With this method, information
contained in the amplitude variation and in the change in
rise time induced by the antagonist is simultaneously
included. As a result, the confidence limits in the estimates
of the two parameters are much narrower and no correlation
is apparent (see Fig. 16.6B in [106]). One possible
limitation of this approach is that it relies on a perfect
match between the kinetic properties of synaptic receptors
and the extrasynaptic ones that are used for determining the
kinetic rates that we mentioned [121]. Furthermore,
especially in brain slices (as opposed to cultured neurons),
the observed rise times of PSCs are affected by the intrinsic
Fig. 4 The peak concentration and time course of neurotransmitter in
the cleft is not unambiguously determined by low-affinity antagonists.
top row The continuous line in the plots shows the combined values of
neurotransmitter peak concentration and decay time that can give rise
to 50% inhibition by low-affinity antagonists. For each receptor
kinetic model, we calculated a dose–inhibition curve with seven
concentrations of antagonists, for a 1 mM · 1 ms agonist pulse. The
dose–inhibition curve was then fitted using the peak agonist
concentration and decay time as the only free parameters. The best
fit was invariably obtained for values very close to 1 mM 1 ms.
bottom row Calculated 95% confidence limit for each fit. The fits span
a 1- or 2-orders-of-magnitude range around the best parameters, with a
high correlation coefficient (>0.99). This implies that despite
convergence of the fitting routine, the two fitted parameters (i.e.,
neurotransmitter peak concentration and decay time) are substantially
undetermined
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resistance and whole cell capacitance) as well as by the
cable filtering, which is more severe for release sites that
are farther away from the soma. Therefore, fitting the time
course of observed PSCs to a kinetic scheme has some
intrinsic limitations, especially for fast currents like AMPAR
or glycine mediated ones. In [88], the authors established
the glutamate concentration in the cleft by combining
information from the dose–inhibition curve and the changes
in rise time observed with the antagonist and/or with a
blocker of glutamate transport. Through this approach, it
was shown that the glutamate transient is best described by
a double exponential waveform with peak concentrations of
2.7 and 0.4 mM and with τdecay=0.1 ms and τdecay=2.1 ms,
respectively. Blocking transporters has the advantage that it
can change the clearance time with negligible effects on the
neurotransmitter peak concentration and therefore can be
assumed to alter independently one of the two correlated
parameters. Accordingly, the comparison of inhibition
before and after block of transporters has been instrumental
in determining the time course for glutamate at AMPARs
[88] and of glycine at synapses onto motoneurons in the
spinal cord [107].
A different but conceptually similar method has been
used for determining the time course of synaptically
released GABA in cultured hippocampal neurons. Instead
of partially occupying the agonist binding sites with an
antagonist, the authors used modulators like chlorproma-
zine or zinc [122, 123] or pH manipulations [110] that
affect (mostly) the agonist binding rates. These manipu-
lations, as noticed by the authors, affect macroscopic
currents evoked by ultra-fast application of transmitter
differently from synaptic currents. This is attributed to
differences between the time course (and in particular
τdecay) of the ultra-fast application and that of synaptically
released GABA. This discrepancy, together with the
determination of the kinetic rates before and after applica-
tion of the modulatory agent, allows determining the time
course of GABA release. The estimate still relies on an
exact description of the kinetics of postsynaptic receptors.
However, its goodness is strongly supported by the fact that
very similar values for the peak concentration and τdecay (2–
3 mM and 0.1 ms, respectively) are estimated with the three
independent approaches (i.e., chlorpromazine, zinc, and
variations in pH).
Sniffers and Imaging Approaches
Various attempts have been made to develop glutamate
sensors as reporters of neurotransmitter release. Excised
patches of cell membranes enriched with high-affinity
receptors, for example, have been used to probe the identity
of the neurotransmitter released from retinal bipolar cells
[124, 125]. The power of this clever design, which in
principle can offer a highly sensitive and temporally precise
read-out of the glutamate transient (depending on the
properties of the receptors in the “sniffer-patch”), is once
again hampered by the relative inaccessibility of the cleft
region at central synapses.
Although the development of such an ideal experimental
tool is still in progress, a number of promising attempts
have been made taking advantage of biochemical engineer-
ing and high-resolution optical detection methods. The trick
here is to have fast and sensitive glutamate reporters
combined with high temporal and spatial resolution
detection of the glutamate transient, but as it might be
expected, the real scenario involves some trade-offs
between all these parameters.
Namiki et al. [126] developed an optical glutamate probe
(glutamate (E) optical sensor, EOS) based on a mutated
AMPAR GluR2 S1S2 ligand-binding domain fused with
the Oregon green dye. The conformational change of the
ligand-binding domain induced by glutamate leads to 40%
increase in the maximal fluorescence intensity of Oregon
green, at the peak of its emission wavelength (520 nm). The
kinetics of the reaction is dictated by the rate of glutamate
binding to the S1S2 domain (10
7M
−1s
−1, if this remains
comparable to that of native S1S2 domains) and the
measured off-rate (0.67 s
−1)[ 126]. The slow dissociation
kinetics, together with a relatively low EC50 (148 nM),
limit the application of EOS to the late and prolonged
phases of neurotransmitter release. In addition, anchoring of
EOS to the cell membrane through a generic biotin–
streptavidin reaction currently precludes any cell-specific
expression of this reporter.
Some of these limitations can be potentially overcome
by using optical probes that are genetically encoded, and
that at least in principle can be fused with proteins
selectively expressed in synaptic or non-synaptic regions.
Recent examples of these genetically encoded optical
probes are the glutamate-sensing fluorescent reporter
(GluSnFR) [127], the more sensitive variant SuperGluSnFR
[128], or the fluorescence indicator protein for glutamate
(FLIPE) [129]. The general design of these reporters
involves fusion of a cyan and yellow fluorescent protein
(CFP and YFP, respectively) to the periplasmic glutamate-
binding protein from E. coli (GltI), and a truncated PDGF
receptor that ensures membrane anchoring of the construct
[128]. The CFP and YFP are chosen because they currently
represent the best pair of fluorescent proteins enabling
fluorescence resonance energy transfer (FRET) [127]. The
conformational change in the S1S2 domain induced by
glutamate binding brings the two fluorophores closer to
each other (<80 Å) leading to the non-radiative energy
transfer from CFP to YFP detected in FRET experiments
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the excitation spectrum of YFP). A series of mutations of
this construct has significantly improved its affinity for
glutamate and the extent of CFP/YFP emission ratio upon
glutamate binding (in Ringer solution, Kd=2.5 μM and
44% change in CFP/YFP emission [128]). The estimated
kinetic properties of SuperGluSnFR, however, seem best
suited for detecting small and slow glutamate transients like
those occurring during the tail of a synaptic event or during
spillover-activation of nearby receptors, as opposed to those
that are attained in the synaptic cleft region. For example, in
cultured hippocampal neurons, the glutamate transient
reported by SuperGluSnFR has a 20–80% rise time=
6.6 ms, [Glu]peak=720 nM, τdecay=40 ms, but the subcel-
lular resolution of the signal is limited by the camera
resolution.
A wide range of imaging techniques could also provide
useful quantitative insights into the diffusion properties of
various molecules inside and outside the synaptic cleft
[130]. For example, fluorescence recovery after photo-
bleaching (FRAP), fluorescence loss in photobleaching
(FLIP), and fluorescence localization after photoactivation
(FLAP) could, in principle, be used to estimate the
characteristics of neurotransmitter diffusion among distinct
subcellular compartments.
With FRAP, the experimental preparation is first equil-
ibrated with a fluorophore, which is then bleached in a
small region with a high-intensity light source (e.g., a
laser). The rate and extent of fluorescence recovery can be
followed in time, providing information on the fluorophore
diffusion between the bleached region and neighboring
ones. This method has been used to analyze inhomogene-
ities in the diffusion coefficient of small and large particles
within the cytoplasm [131]. A modified but related
approach consists of constantly bleaching the fluorophore
at a particular site and monitoring the FLIP at a nearby
location to examine the exchange in fluorescence between
the bleached and neighboring sites. If the fluorophore has
similar biophysical properties to those of the neurotrans-
mitter of interest, one could possibly determine how far and
how quickly it travels away from the bleached area [132].
The general principles of these two techniques are also
shared by FLAP, where one follows the localization of a
photoactivated molecule, like PA-GFP [133] or Dronpa
[134], or of a fluorescent molecule that changes its
spectrum of emission upon exposure to UV light (e.g.,
Kaede [135]). The advantage of these techniques is that
they can be used in confocal or two-photon microscopy set-
ups, but are limited, however, by the temporal and spatial
resolution of these systems.
That is why the development of other techniques has
become so crucial. Particularly noteworthy are fluorescence
lifetime imaging (FLIM) and fluorescence correlation
spectroscopy (FCS) [136], which have sub-microsecond
time limits, or photoactivated localization microscopy
(PALM) and single-particle tracking PALM (sptPALM)
[137], which significantly enhance the spatial resolution of
the signal emitted by labeled molecules [138, 139]. With
FLIM, one measures the exponential decay in the emission
intensity of a fluorophore (i.e., its lifetime). This measure is
independent of the fluorophore concentration, but changes
if the environment surrounding the fluorophore (e.g.,
polarity, ion concentration, and viscosity) alters its elec-
tronic state. Fluorescence lifetimes can be measured in the
time and frequency domains, and have been used in
biological systems to measure ionic concentrations (Ca
2+,
Cl
−,O 2) or the subcellular localization of various macro-
molecules [140]. This technique can also be combined with
FCS [141] to determine the diffusion coefficient of
fluorescent molecules within a known volume [140]. An
interesting variation of FCS, scanning FCS (sFCS), does
not require a priori knowledge of the measurement volume,
and therefore is probably better suited for diffusion
estimates in living systems [142].
A recently developed approach, sptPALM, has enabled
tracking of single fluorescent protein chimeras with
nanometer spatial resolution. This allows one to obtain
maps of single-molecule diffusion that can be useful to
study cell dynamics, as well as the properties of subcellular
microenvironments. It would be of interest to test whether
this kind of approach could be used to study the diffusion
profile of smaller molecules, like neurotransmitters, partic-
ularly in living tissues. These and other techniques are
constantly being refined and their application to synaptic
physiology is expected to enable the investigation of
aspects of synaptic transmission and neurotransmitter
diffusion that are currently precluded by indirect pharma-
cological and modeling approaches.
Conclusions
The problem of the determination of the time course of
transmitter in the cleft has spanned more than 60 years of
neuroscience research and a number of direct and indirect
approaches have been used to determine this elusive
variable. Despite all the efforts, we are still far from a
definite consensus, even for the most studied synapses in
the central nervous system. Old techniques and innovative
approaches have been devised that are continuously
challenged by the advent of improved technologies that
can resolve events on a faster time scale and with better
spatial resolution. In this review, we highlighted the
advantages and pitfalls of each method that has been used
in the past and analyzed the potential of new optical
techniques that in the future could provide quantitative
302 Mol Neurobiol (2009) 40:289–306descriptions of the fundamental mechanisms underlying the
dynamics of inter-neuronal signaling. It is likely that
refinement of these novel approaches will ultimately
answer many open questions that have haunted neuro-
scientists since the demonstration of quantal release of
neurotransmitter as the main form of communication
between neuronal cells.
Acknowledgments A.S. is supported by the NINDS Intramural
Research Program and Human Frontier Science Program (RGP50/
2006). M.B. is a Royal Society University Research Fellow and
recipient of a Wellcome Trust Grant (Project Grant 07662/Z/05/A).
The Authors would like to thank D.M. Kullmann, K.A. Pelkey and L.
G. Wu for valuable comments on the manuscript.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Banks MI, Li TB, Pearce RA (1998) The synaptic basis of
GABAA, slow. J Neurosci 18(4):1305–1317
2. Lu T, Rubio ME, Trussell LO (2008) Glycinergic transmission
shaped by the corelease of GABA in a mammalian auditory
synapse. Neuron 57(4):524–535
3. Szabadics J, Tamas G, Soltesz I (2007) Different transmitter
transients underlie presynaptic cell type specificity of GABAA,
slow and GABAA, fast. Proc Natl Acad Sci U S A 104
(37):14831–14836
4. Szapiro G, Barbour B (2007) Multiple climbing fibers signal to
molecular layer interneurons exclusively via glutamate spillover.
Nat Neurosci 10(6):735–742
5. Huang EP, Stevens CF (1997) Estimating the distribution of
synaptic reliabilities. J Neurophysiol 78(6):2870–2880
6. Nusser Z, Lujan R, Laube G, Roberts JDB, Molnar E, Somogyi P
(1998)CelltypeandpathwaydependenceofsynapticAMPAreceptor
number and variability in the hippocampus. Neuron 21(3):545–559
7. Racca C, Stephenson FA, Streit P, Roberts JD, Somogyi P (2000)
NMDA receptor content of synapses in stratum radiatum of the
hippocampal CA1 area. J Neurosci 20(7):2512–2522
8. Schikorski T, Stevens CF (1997) Quantitative ultrastructural
analysis of hippocampal excitatory synapses. J Neurosci 17
(15):5858–5867
9. Takumi Y, Ramirez-Leon V, Laake P, Rinvik E, Ottersen OP
(1999) Different modes of expression of AMPA and NMDA
receptors in hippocampal synapses. Nat Neurosci 2(7):618–624
10. Ventura R, Harris KM (1999) Three-dimensional relationships
between hippocampal synapses and astrocytes. J Neurosci 19
(16):6897–6906
11. Acheson GH (1948) Physiology of neuro-muscular junctions;
chemical aspects. Fed Proc 7(3):447–457
12. Krnjevic K, Miledi R (1958) Acetylcholine in mammalian
neuromuscular transmission. Nature 182(4638):805–806
13. Kuffler SW, Yoshikami D (1975) The number of transmitter
molecules in a quantum: an estimate from iontophoretic
application of acetylcholine at the neuromuscular synapse. J
Physiol 251(2):465–482
14. Hartzell HC, Kuffler SW, Yoshikami D (1975) Post-synaptic
potentiation: interaction between quanta of acetylcholine at the
skeletal neuromuscular synapse. J Physiol 251(2):427–463
15. Matthews-Bellinger J, Salpeter MM (1978) Distribution of acetyl-
choline receptors at frog neuromuscular junctions witha discussion of
some physiological implications. J Physiol 279:197–213
16. Wightman RM, Jankowski JA, Kennedy RT, Kawagoe KT,
Schroeder TJ, Leszczyszyn DJ, Near JA, Diliberto EJ Jr, Viveros
OH (1991) Temporally resolved catecholamine spikes corre-
spond to single vesicle release from individual chromaffin cells.
Proc Natl Acad Sci U S A 88(23):10754–10758
17. Pothos EN, Davila V, Sulzer D (1998) Presynaptic recording of
quanta from midbrain dopamine neurons and modulation of the
quantal size. J Neurosci 18(11):4106–4118
18. Burger PM, Mehl E, Cameron PL, Maycox PR, Baumert M,
Lottspeich F, De Camilli P, Jahn R (1989) Synaptic vesicles
immunoisolated from rat cerebral cortex contain high levels of
glutamate. Neuron 3(6):715–720
19. Riveros N, Fiedler J, Lagos N, Munoz C, Orrego F (1986)
Glutamate in rat brain cortex synaptic vesicles: influence of the
vesicle isolation procedure. Brain Res 386(1–2):405–408
20. Takamori S, Holt M, Stenius K, Lemke EA, Grønborg M, Riedel
D, Urlaub H, Schenck S, Brügger B, Ringler P, Müller SA,
Rammner B, Gräter F, Hub JS, De Groot BL, Mieskes G,
Moriyama Y, Klingauf J, Grubmüller H, Heuser J, Wieland F,
Jahn R (2006) Molecular anatomy of a trafficking organelle. Cell
127(4):831–846
21. Harata N, Ryan TA, Smith SJ, Buchanan J, Tsien RW (2001)
Visualizing recycling synaptic vesicles in hippocampal neurons
by FM 1–43 photoconversion. Proc Natl Acad Sci U S A 98
(22):12748–12753
22. Bekkers JM,RichersonGB,StevensCF(1990)Originofvariability
in quantal size in cultured hippocampal neurons and hippocampal
slices. Proc Natl Acad Sci U S A 87(14):5359–5362
23. Sulzer D, Edwards R (2000) Vesicles: equal in neurotransmitter
concentration but not in volume. Neuron 28(1):5–7
24. Wu XS, Xue L, Mohan R, Paradiso K, Gillis KD, Wu LG (2007)
The origin of quantal size variation: vesicular glutamate concentra-
tion plays a significant role. J Neurosci 27(11):3046–3056
25. Daniels RW, Collins CA, Chen K, Gelfand MV, Featherstone
DE, DiAntonio A (2006) A single vesicular glutamate transport-
er is sufficient to fill a synaptic vesicle. Neuron 49(1):11–16
26. Schikorski T, Stevens CF (2001) Morphological correlates of
functionally defined synaptic vesicle populations. Nat Neurosci 4
(4):391–395
27. Sorra KE, Harris KM (1993) Occurrence and three-dimensional
structure of multiple synapses between individual radiatum
axons and their target pyramidal cells in hippocampal area
CA1. J Neurosci 13(9):3736–3748
28. Gulyas AI, Miles R, Sík A, Tóth K, Tamamaki N, Freund TF
(1993) Hippocampal pyramidal cells excite inhibitory neurons
through a single release site. Nature 366(6456):683–687
29. Triller A, Korn H (1982) Transmission at a central inhibitory
synapse. III. Ultrastructure of physiologically identified and
stained terminals. J Neurophysiol 48(3):708–736
30. Auger C, Kondo S, Marty A (1998) Multivesicular release at
single functional synaptic sites in cerebellar stellate and basket
cells. J Neurosci 18(12):4532–4547
31. Korn H, Sur C, Charpier S, Legendre P, Faber DS (1994) The
one-vesicle hypothesis and multivesicular release. Adv Second
Messenger Phosphoprotein Res 29:301–322
32. Christie JM, Jahr CE (2006) Multivesicular release at Schaffer
collateral-CA1 hippocampal synapses. J Neurosci 26(1):210–216
33. Conti R, Lisman J (2003) The high variance of AMPA receptor-
and NMDA receptor-mediated responses at single hippocampal
synapses: evidence for multiquantal release. Proc Natl Acad Sci
U S A 100(8):4885–4890
34. Foster KA, Crowley JJ, Regehr WG (2005) The influence of
multivesicular release and postsynaptic receptor saturation on
Mol Neurobiol (2009) 40:289–306 303transmission at granule cell to Purkinje cell synapses. J Neurosci
25(50):11655–11665
35. Korn H, Bausela F, Charpier S, Faber DS (1993) Synaptic noise
and multiquantal release at dendritic synapses. J Neurophysiol 70
(3):1249–1254
36. Oertner TG, Sabatini BL, Nimchinsky EA, Svoboda K (2002)
Facilitation at single synapses probed with optical quantal
analysis. Nat Neurosci 5(7):657–664
37. Prange O, Murphy TH (1999) Analysis of multiquantal
transmitter release from single cultured cortical neuron termi-
nals. J Neurophysiol 81(4):1810–1817
38. Singer JH, Lassova L, Vardi N, Diamond JS (2004) Coordinated
multivesicular release at a mammalian ribbon synapse. Nat
Neurosci 7(8):826–833
39. Tong G, Jahr CE (1994) Multivesicular release from excitatory
synapses of cultured hippocampal neurons. Neuron 12(1):51–59
40. Wadiche JI, Jahr CE (2001) Multivesicular release at climbing
fiber-Purkinje cell synapses. Neuron 32(2):301–313
41. Higley MJ, Soler-Llavina GJ, Sabatini BL (2009) Cholinergic
modulation of multivesicular release regulates striatal synaptic
potency and integration. Nat Neurosci 12(9):1121–1128
42. Liu G, Choi S, Tsien RW (1999) Variability of neurotransmitter
concentration and nonsaturation of postsynaptic AMPA receptors
at synapses in hippocampal cultures and slices. Neuron 22
(2):395–409
43. Asztely F, Erdemli G, Kullmann DM (1997) Extrasynaptic
glutamate spillover in the hippocampus: dependence on tempera-
ture andthe role ofactive glutamate uptake. Neuron18(2):281–293
44. Ceccarelli B, Hurlbut WP, Mauro A (1972) Depletion of vesicles
from frog neuromuscular junctions by prolonged tetanic stimu-
lation. J Cell Biol 54(1):30–38
45. Heuser JE, Reese TS (1973) Evidence for recycling of synaptic
vesicle membrane during transmitter release at the frog neuro-
muscular junction. J Cell Biol 57(2):315–344
46. Chow RH, von Ruden L, Neher E (1992) Delay in vesicle fusion
revealed by electrochemical monitoring of single secretory
events in adrenal chromaffin cells. Nature 356(6364):60–63
47. He L, Wu XS, Mohan R, Wu LG (2006) Two modes of fusion
pore opening revealed by cell-attached recordings at a synapse.
Nature 444(7115):102–105
48. Harata NC, Choi S, Pyle JL, Aravanis AM, Tsien RW (2006)
Frequency-dependent kinetics and prevalence of kiss-and-run
and reuse at hippocampal synapses studied with novel quenching
methods. Neuron 49(2):243–256
49. Zhang Q, Li Y, Tsien RW (2009) The dynamic control of kiss-
and-run and vesicular reuse probed with single nanoparticles.
Science 323(5920):1448–1453
50. Fernandez JM, Neher E, Gomperts BD (1984) Capacitance
measurements reveal stepwise fusion events in degranulating
mast cells. Nature 312(5993):453–455
51. Neher E, Marty A (1982) Discrete changes of cell membrane
capacitance observed under conditions of enhanced secretion in
bovine adrenal chromaffin cells. Proc Natl Acad Sci U S A 79
(21):6712–6716
52. Almers W, Breckenridge LJ, Iwata A, Lee AK, Spruce AE, Tse
FW (1991) Millisecond studies of single membrane fusion
events. Ann N Y Acad Sci 635:318–327
53. Spruce AE, Breckenridge LJ, Lee AK, Almers W (1990)
Properties of the fusion pore that forms during exocytosis of a
mast cell secretory vesicle. Neuron 4(5):643–654
54. Aravanis AM, Pyle JL, Tsien RW (2003) Single synaptic
vesicles fusing transiently and successively without loss of
identity. Nature 423(6940):643–647
55. Gandhi SP, Stevens CF (2003) Three modes of synaptic vesicular
recycling revealed by single-vesicle imaging. Nature 423
(6940):607–613
56. Balaji J, Ryan TA (2007) Single-vesicle imaging reveals that
synaptic vesicle exocytosis and endocytosis are coupled by a
single stochastic mode. Proc Natl Acad Sci U S A 104
(51):20576–20581
57. Granseth B, Odermatt B, Royle SJ, Lagnado L (2006) Clathrin-
mediated endocytosis is the dominant mechanism of vesicle
retrieval at hippocampal synapses. Neuron 51(6):773–786
58. Chen X, Barg S, Almers W (2008) Release of the styryl dyes
from single synaptic vesicles in hippocampal neurons. J Neurosci
28(8):1894–1903
59. Renden R, von Gersdorff H (2007) Synaptic vesicle endocytosis
at a CNS nerve terminal: faster kinetics at physiological
temperatures and increased endocytotic capacity during matura-
tion. J Neurophysiol 98(6):3349–3359
60. Zhang Q, Cao YQ, Tsien RW (2007) Quantum dots provide an
optical signal specific to full collapse fusion of synaptic vesicles.
Proc Natl Acad Sci U S A 104(45):17843–17848
61. Eccles JC, Jaeger JC (1958) The relationship between the mode of
operation and the dimensions of the junctional regions at synapses
andmotorend-organs.ProcRSocLondBBiolSci148(930):38–56
62. Katz B, Miledi R (1973) The binding of acetylcholine to
receptors and its removal from the synaptic cleft. J Physiol 231
(3):549–574
63. Magleby KL, Stevens CF (1972) The effect of voltage on the
time course of end-plate currents. J Physiol 223(1):151–171
64. Eccles JC, Mac FW (1949) Actions of anti-cholinesterases on
endplate potential of frog muscle. J Neurophysiol 12(1):59–80
65. Hill AV (1936) Excitation and accommodation in nerve.
Proceedings of the Royal Society of London Series B,
Biological Sciences 119(814):305–355
66. Eccles JC, Katz B, Kuffler SW (1941) Nature of the “endplate
potential” in curarized muscle. J Neurophysiol 4:362–387
67. Nicholson C, Phillips JM (1981) Ion diffusion modified by
tortuosity and volume fraction in the extracellular microenviron-
ment of the rat cerebellum. J Physiol 321:225–257
68. Sykova E, Nicholson C (2008) Diffusion in brain extracellular
space. Physiol Rev 88(4):1277–1340
69. Nicholson C, Sykova E (1998) Extracellular space structure
revealed by diffusion analysis. Trends Neurosci 21(5):207–215
70. Rusakov DA, Kullmann DM (1998) Extrasynaptic glutamate
diffusion in the hippocampus: ultrastructural constraints, uptake,
and receptor activation. J Neurosci 18(9):3158–3170
71. Tao A, Tao L, Nicholson C (2005) Cell cavities increase tortuosity
in brain extracellular space. J Theor Biol 234(4):525–536
72. Hrabe J, Hrabetova S, Segeth K (2004) A model of effective
diffusion and tortuosity in the extracellular space of the brain.
Biophys J 87(3):1606–1617
73. Hrabetova S, Nicholson C (2004) Contribution of dead-space
microdomains to tortuosity of brain extracellular space. Neuro-
chem Int 45(4):467–477
74. Tao L, Nicholson C (2004) Maximum geometrical hindrance to
diffusion in brain extracellular space surrounding uniformly
spaced convex cells. J Theor Biol 229(1):59–68
75. Nicholson C, Tao L (1993) Hindered diffusion of high molecular
weight compounds in brain extracellular microenvironment
measured with integrative optical imaging. Biophys J 65
(6):2277–2290
76. Savtchenko LP, Rusakov DA (2005) Extracellular diffusivity
determines contribution of high-versus low-affinity receptors to
neural signaling. Neuroimage 25(1):101–111
77. Thorne RG, Nicholson C (2006) In vivo diffusion analysis with
quantum dots and dextrans predicts the width of brain extracel-
lular space. Proc Natl Acad Sci U S A 103(14):5567–5572
78. Zheng K, Scimemi A, Rusakov DA (2008) Receptor actions of
synaptically released glutamate: the role of transporters on the
scale from nanometers to microns. Biophys J 95(10):4584–4596
304 Mol Neurobiol (2009) 40:289–30679. Levin VA, Fenstermacher JD, Patlak CS (1970) Sucrose and
inulin space measurements of cerebral cortex in four mammalian
species. Am J Physiol 219(5):1528–1533
80. Nielsen TA, DiGregorio DA, Silver RA (2004) Modulation of
glutamate mobility reveals the mechanism underlying slow-
rising AMPAR EPSCs and the diffusion coefficient in the
synaptic cleft. Neuron 42(5):757–771
81. Barbour B (2001) An evaluation of synapse independence. J
Neurosci 21(20):7969–7984
82. Franks KM, Bartol TM Jr, Sejnowski TJ (2002) A Monte Carlo
model reveals independent signaling at central glutamatergic
synapses. Biophys J 83(5):2333–2348
83. Kullmann DM, Min MY, Asztely F, Rusakov DA (1999)
Extracellular glutamate diffusion determines the occupancy of
glutamate receptors at CA1 synapses in the hippocampus. Philos
Trans R Soc Lond B Biol Sci 354(1381):395–402
84. Longsworth LG (1953) Diffusion measurements, at 25-degrees, of
aqueous solutions of amino acids, peptides and sugars. J Am Chem
Soc 75(22):5705–5709
85. Min MY, Rusakov DA, Kullmann DM (1998) Activation of
AMPA, kainate, and metabotropic receptors at hippocampal
mossy fiber synapses: role of glutamate diffusion. Neuron 21
(3):561–570
86. Pouille F, Scanziani M (2001) Enforcement of temporal fidelity
in pyramidal cells by somatic feed-forward inhibition. Science
293(5532):1159–1163
87. Bergles DE, Jahr CE (1997) Synaptic activation of glutamate
transporters in hippocampal astrocytes. Neuron 19(6):1297–1308
88. Diamond JS, Jahr CE (1997) Transporters buffer synaptically
released glutamate on a submillisecond time scale. J Neurosci 17
(12):4672–4687
89. Wadiche JI, Arriza JL, Amara SG, Kavanaugh MP (1995) Kinetics
of a human glutamate transporter. Neuron 14(5):1019–1027
90. Lehre KP, Danbolt NC (1998) The number of glutamate
transporter subtype molecules at glutamatergic synapses: chem-
ical and stereological quantification in young adult rat brain. J
Neurosci 18(21):8751–8757
91. Levy LM, Lehre KP, Walaas SI, Storm-Mathisen J, Danbolt NC
(1995) Down-regulation of glial glutamate transporters after
glutamatergic denervation in the rat brain. Eur J NeuroSci 7
(10):2036–2041
92. Diamond JS (2005) Deriving the glutamate clearance time course
from transporter currents in CA1 hippocampal astrocytes:
transmitter uptake gets faster during development. J Neurosci
25(11):2906–2916
93. Arnth-Jensen N, Jabaudon D, Scanziani M (2002) Cooperation
between independent hippocampal synapses is controlled by
glutamate uptake. Nat Neurosci 5(4):325–331
94. Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE
(2004) Astrocyte glutamate transporters regulate metabotropic
glutamate receptor-mediated excitation of hippocampal inter-
neurons. J Neurosci 24(19):4551–4559
95. Scimemi A, Fine A, Kullmann DM, Rusakov DA (2004) NR2B-
containing receptors mediate cross talk among hippocampal
synapses. J Neurosci 24(20):4767–4777
96. Brasnjo G, Otis TS (2001) Neuronal glutamate transporters control
activation of postsynaptic metabotropic glutamate receptors and
influence cerebellar long-term depression. Neuron 31(4):607–616
97. Dehnes Y, Chaudhry FA, Ullensvang K, Lehre KP, Storm-Mathisen
J, Danbolt NC (1998) The glutamate transporter EAAT4 in rat
cerebellar Purkinje cells: a glutamate-gated chloride channel
concentrated near the synapse in parts of the dendritic membrane
facing astroglia. J Neurosci 18(10):3606–3619
98. Diamond JS (2001) Neuronal glutamate transporters limit
activation of NMDA receptors by neurotransmitter spillover on
CA1 pyramidal cells. J Neurosci 21(21):8328–8338
99. Fatt P (1954) Biophysics of junctional transmission. Physiol Rev
34(4):674–710
100. Ogston AG (1955) Removal of acetylcholine from a limited
volume by diffusion. J Physiol 128(1):222–223
101. FattP,KatzB(1951)Ananalysisoftheend-platepotentialrecorded
with an intracellular electrode. J Physiol 115(3):320–370
102. Bartol TM Jr, Land BR, Salpeter EE, Salpeter MM (1991) Monte
Carlo simulation of miniature endplate current generation in the
vertebrate neuromuscular junction. Biophys J 59(6):1290–1307
103. Kruk PJ, Korn H, Faber DS (1997) The effects of geometrical
parameters on synaptic transmission: a Monte Carlo simulation
study. Biophys J 73(6):2874–2890
104. Wahl LM, Pouzat C, Stratford KJ (1996) Monte Carlo simulation
of fast excitatory synaptic transmission at a hippocampal
synapse. J Neurophysiol 75(2):597–608
105. Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL
(1992) The time course of glutamate in the synaptic cleft.
Science 258(5087):1498–1501
106. Overstreet LS, Westbrook GL, Jones MV (2003) Measuring and
modeling the spatiotemporal profile of GABA at the synapse. In:
Quick MW (ed) Transmembrane transporters. Wiley-Liss, New
York, pp 259–276
107. Beato M (2008) The time course of transmitter at glycinergic
synapses onto motoneurons. J Neurosci 28(29):7412–7425
108. Beato M, Sivilotti LG (2007) Single-channel properties of
glycine receptors of juvenile rat spinal motoneurones in vitro. J
Physiol 580(Pt. 2):497–506
109. Burzomato V, Beato M, Groot-Kormelink PJ, Colquhoun D,
Sivilotti LG (2004) Single-channel behavior of heteromeric
alpha1beta glycine receptors: an attempt to detect a conforma-
tional change before the channel opens. J Neurosci 24
(48):10924–10940
110. Mozrzymas JW, Barberis A, Mercik K, Zarnowska ED (2003)
Binding sites, singly bound states, and conformation coupling
shape GABA-evoked currents. J Neurophysiol 89(2):871–883
111. Raman IM, Trussell LO (1995) Concentration-jump analysis of
voltage-dependent conductances activated by glutamate and kainate
in neurons of the avian cochlear nucleus. Biophys J 69(5):1868–
1879
112. Pitt SJ, Sivilotti LG, Beato M (2008) High intracellular chloride
slows the decay of glycinergic currents. J Neurosci 28
(45):11454–11467
113. Beato M, Groot-Kormelink PJ, Colquhoun D, Sivilotti LG
(2004) The activation mechanism of alpha1 homomeric glycine
receptors. J Neurosci 24(4):895–906
114. Banke TG, Traynelis SF (2003) Activation of NR1/NR2B
NMDA receptors. Nat Neurosci 6(2):144–152
115. Celentano JJ, Hawkes AG (2004) Use of the covariance matrix
in directly fitting kinetic parameters: application to GABAA
receptors. Biophys J 87(1):276–294
116. Lu W, Shi Y, Jackson AC, Bjorgan K, During MJ, Sprengel R,
Seeburg PH, Nicoll RA (2009) Subunit composition of synaptic
AMPA receptors revealed by a single-cell genetic approach.
Neuron 62(2):254–268
117. Legendre P, Muller E, Badiu CI, Meier J, Vannier C, Triller A
(2002) Desensitization of homomeric alpha1 glycine receptor
increases with receptor density. Mol Pharmacol 62(4):817–827
118. Del Castillo J, Katz B (1957) Interaction at end-plate receptors
between different choline derivatives. Proc R Soc Lond B Biol
Sci 146(924):369–381
119. Colquhoun D, Hawkes AG (1982) On the stochastic properties
of bursts of single ion channel openings and of clusters of bursts.
Philos Trans R Soc Lond B Biol Sci 300(1098):1–59
120. Colquhoun D, Hawkes AG, Merlushkin A, Edmonds B (1997)
Properties of single ion channel currents elicited by a pulse of
agonist concentration or voltage. Philosophical Transactions of
Mol Neurobiol (2009) 40:289–306 305the Royal Society of London Series A—Mathematical Physical
and Engineering Sciences 355(1730):1743–1786
121. Jones MV, Westbrook GL (1995) Desensitized states prolong
GABAA channel responses to brief agonist pulses. Neuron 15
(1):181–191
122. Barberis A, Cherubini E, Mozrzymas JW (2000) Zinc inhibits
miniature GABAergic currents by allosteric modulation of
GABAA receptor gating. J Neurosci 20(23):8618–8627
123. Mozrzymas JW, Barberis A, Michalak K, Cherubini E (1999)
Chlorpromazine inhibits miniature GABAergic currents by
reducing the binding and by increasing the unbinding rate of
GABAA receptors. J Neurosci 19(7):2474–2488
124. Allen TG (1997) The ‘sniffer-patch’ technique for detection of
neurotransmitter release. Trends Neurosci 20(5):192–197
125. Copenhagen DR, Jahr CE (1989) Release of endogenous
excitatory amino acids from turtle photoreceptors. Nature 341
(6242):536–539
126. Namiki S, Sakamoto H, Iinuma S, Iino M, Hirose K (2007)
Optical glutamate sensor for spatiotemporal analysis of synaptic
transmission. Eur J NeuroSci 25(8):2249–2259
127. Tsien RY (2005) Building and breeding molecules to spy on cells
and tumors. FEBS Lett 579(4):927–932
128. Hires SA, Zhu Y, Tsien RY (2008) Optical measurement of
synaptic glutamate spillover and reuptake by linker optimized
glutamate-sensitive fluorescent reporters. Proc Natl Acad Sci U S
A 105(11):4411–4416
129. Okumoto S, Looger LL, Micheva KD, Reimer RJ, Smith SJ,
Frommer WB (2005) Detection of glutamate release from
neurons by genetically encoded surface-displayed FRET nano-
sensors. Proc Natl Acad Sci U S A 102(24):8740–8745
130. Botvinick EL, Shah JV (2007) Laser-based measurements in cell
biology. Methods Cell Biol 82:81–109
131. Luby-Phelps K, Taylor DL (1988) Subcellular compartmentali-
zation by local differentiation of cytoplasmic structure. Cell
Motil Cytoskeleton 10(1–2):28–37
132. Belaya K, Tollervey D, Kos M (2006) FLIPing heterokaryons to
analyze nucleo-cytoplasmic shuttling of yeast proteins. RNA 12
(5):921–930
133. Patterson GH, Lippincott-Schwartz J (2002) A photoactivatable
GFP for selective photolabeling of proteins and cells. Science
297(5588):1873–1877
134. Habuchi S, Ando R, Dedecker P, Verheijen W, Mizuno H,
Miyawaki A, Hofkens J (2005) Reversible single-molecule
photoswitching in the GFP-like fluorescent protein Dronpa. Proc
Natl Acad Sci U S A 102(27):9511–9516
135. Ando R, Hama H, Yamamoto-Hino M, Mizuno H, Miyawaki A
(2002) An optical marker based on the UV-induced green-to-red
photoconversion of a fluorescent protein. Proc Natl Acad Sci U S
A 99(20):12651–12656
136. Medina MA, Schwille P (2002) Fluorescence correlation
spectroscopy for the detection and study of single molecules in
biology. Bioessays 24(8):758–764
137. Manley S, Gillette JM, Patterson GH, Shroff H, Hess HF, Betzig
E, Lippincott-Schwartz J (2008) High-density mapping of single-
molecule trajectories with photoactivated localization microsco-
py. Nat Methods 5(2):155–157
138. Betzig E, Patterson GH, Sougrat R, Lindwasser OW,
Olenych S, Bonifacino JS, Davidson MW, Lippincott-
Schwartz J, Hess HF (2006) Imaging intracellular fluores-
cent proteins at nanometer resolution. Science 313(5793):
1642–1645
139. Shroff H, Galbraith CG, Galbraith JA, Betzig E (2008) Live-cell
photoactivated localization microscopy of nanoscale adhesion
dynamics. Nat Methods 5(5):417–423
140. Breusegem SY, Levi M, Barry NP (2006) Fluorescence
correlation spectroscopy and fluorescence lifetime imaging
microscopy. Nephron Exp Nephrol 103(2):e41–49
141. Petrasek Z, Krishnan M, Monch I, Schwille P (2007) Simulta-
neous two-photon fluorescence correlation spectroscopy and
lifetime imaging of dye molecules in submicrometer fluidic
structures. Microsc Res Tech 70(5):459–466
142. Petrasek Z, Schwille P (2008) Precise measurement of diffusion
coefficients using scanning fluorescence correlation spectrosco-
py. Biophys J 94(4):1437–1448
143. Stiles JR, Bartol TM Jr (2001) Monte Carlo methods for simulating
realistic synaptic microphysiology using MCell pp 87-127.
144. Stiles JR, Van Helden D, Bartol TM Jr, Salpeter EE,
Salpeter MM (1996) Miniature endplate current rise times
less than 100 microseconds from improved dual recordings
can be modeled with passive acetylcholine diffusion from a
synaptic vesicle. Proc Natl Acad Sci U S A 93(12):5747–
5752
306 Mol Neurobiol (2009) 40:289–306